Moschovakis Capital publishes institutional-grade equity research on companies we believe are trading below intrinsic value. Every thesis follows our proprietary framework: business fundamentals, valuation discipline, management quality, and strict risk control. These are not stock tips. This is deep fundamental analysis designed for serious capital allocators.
Follow the Research With Real Capital
Every thesis below is backed by real capital. Angelos Moschovakis is a verified eToro Popular Investor — copy the full equity portfolio and access these positions automatically.
New to eToro? Open an account here and start copying.
eToro is a multi-asset platform. The value of your investments may go up or down. Your capital is at risk. Copy trading does not amount to investment advice. Past performance is not an indication of future results.
Get the Research Delivered
Institutional equity research. Delivered free to your inbox when we publish. No spam. No hype. Just analysis.
APO Stock Analysis: 29% Upside Case for 2026 – Institutional Research Note
Apollo Global Management (NYSE: APO) represents one of the most compelling watchlist opportunities in alternative asset management today. This APO stock analysis examines whether the
AMPH Stock Analysis: 50% Upside Case for 2026 – Institutional Research Note
This AMPH stock analysis examines Amphastar Pharmaceuticals (NASDAQ: AMPH) through the lens of institutional wealth preservation — identifying whether the current 67% drawdown from all-time
CPRX Stock Analysis: 44% Upside Case for 2026 – Institutional Research Note
This CPRX stock analysis examines Catalyst Pharmaceuticals (NASDAQ: CPRX), a rare disease pharmaceutical company trading at just 10x forward earnings with zero debt, $709 million
MercadoLibre Stock Analysis: 23% Upside Case for 2026 – Institutional Research Note
This MercadoLibre stock analysis examines Latin America’s dominant e-commerce and fintech ecosystem through the lens of our proprietary Wealth Preservation Framework. At $1,774 per share,
Birkenstock Stock Analysis: 39% Upside Case for 2026 – Institutional Research Note
Birkenstock Stock Analysis — Executive Summary RECOMMENDATION: BUY ON WEAKNESS | Target Entry: $36.00–$38.00 Metric Value Current Price (USD) $39.91 Fair Value — Base Case
Logitech Stock Analysis: 21% Upside Case for 2026 – Institutional Research Note
Logitech Stock Analysis: Executive Summary BOTTOM LINE UP FRONT Metric Value Recommendation BUY Current Price $89.79 Fair Value (Base Case) $108.50 Margin of Safety 17.2%
AMZN Stock Analysis: 17% Upside Case for 2026 – Institutional Research Note
AMZN Stock Analysis: Executive Summary BOTTOM LINE UP FRONT Metric Value Recommendation HOLD / WATCHLIST Current Price $210.11 Fair Value (Base Case) $245.00 Target Entry
FICO Stock Analysis: 41% Upside Case for 2026 – Institutional Research Note
Executive Summary BOTTOM LINE UP FRONT Metric Value Recommendation BUY Current Price $1,283 Fair Value (Base Case) $2,180 Margin of Safety 41.1% Wealth Preservation Score
BKNG Stock Analysis: 43% Upside Case for 2026 – Institutional Research Note
This BKNG stock analysis examines why Booking Holdings (NASDAQ: BKNG) represents one of the most compelling asymmetric opportunities in the travel services sector today. After